Page could not be found
Here are some recommended pages that may interested you
Disclosure UK 2025: the 11th year of Disclosure UK data, with industry transparency continuing to grow
Dr Amit Aggarwal, ÐÇ¿ÕÊÓÆµ Executive Director of Medical Affairs and Strategic Partnerships, and Alex Fell, PMCPA Chief Executive, discuss the latest data published on Disclosure UK, the industry database which records payments and benefits in kind from pharmaceutical companies to ÐÇ¿ÕÊÓÆµ and other healthcare organisations and healthcare professionals.
Improved early warning systems needed to reduce medicines supply risks, says ÐÇ¿ÕÊÓÆµ
A new report from the Association of the British Pharmaceutical Industry sets out the leading causes of medicine supply shocks, alongside a plan to further strengthen UK medicines supply chains to protect patients when disruptions occur.
ÐÇ¿ÕÊÓÆµ celebrates a month of major investment commitments into UK life sciences
Following two new major investments in UK life sciences in April - £300 million by AstraZeneca, and £150 million by Boehringer Ingelheim - the ÐÇ¿ÕÊÓÆµ points to the real progress unlocked by the landmark UK-U.S. Pharmaceutical arrangement.
3rd Annual Regulatory Science Symposium
Registration is now open for our 3rd Annual Regulatory Science Symposium. Please note this is open to ÐÇ¿ÕÊÓÆµ Members and invited guests only.
If you have any questions about the event please contact events@abpi.org.uk
Last reviewed date: 08 October 2021
Next review date: 08 October 2024